This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

CIS Insulin Market

Market Insights on CIS Insulin covering sales outlook, demand forecast & up-to-date key trends

CIS Insulin Market by Product, Capacity, Application, Distribution Channel & Region - Forecast 2022 - 2032

CIS Insulin Market Outlook (2022-2032)

[297 Pages Report] The global CIS insulin market is expected to reach US$ 465 Million by 2022. An increasing number of diabetic patients are estimated to further increase the demand for CIS insulin. During the forecast period ranging from 2022-2032, the market is projected to grow at a CAGR of 2.7%, totaling around US$ 600 Million by the end of 2032. As of 2021, the market was valued at US$ 455 Million, which experienced a Y-o-Y growth rate of 2.2% in 2022.

Report Attribute

Key Statistics

Expected Base Year Value (2021)

US$ 455 Million

Anticipated Current Value (2022)

US$ 465 Million

Projected Forecast Value (2032)

US$ 600 Million

Global Growth Rate (2022-2032)

2.7% CAGR

Insulin is considered to be the main anabolic hormone of the body produced by beta cells in the pancreas. It regulates metabolism by promoting the absorption of glucose from the blood into the liver, fat, and skeletal muscle cells. Insufficient production of insulin leads to the accumulation of sugar in blood cells which causes diabetes.

The most common is type 2 diabetes, usually in adults, which occurs when the body becomes resistant to insulin or doesn't make enough insulin. In the past three decades, the prevalence of type 2 diabetes has risen dramatically in countries of all income levels. Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin by itself.

Regionally, North America, spearheaded by the U.S. dominates the global CIS insulin market, during the forecast period. The market is likely to garner US$ 33 Million while exhibiting a CAGR of 3.4% from 2022 to 2032. Growth in the North American CIS Insulin market is driven by the increasing prevalence rate of diabetes and metabolic diseases, and the strong presence of leading CIS Insulin market players in the region.

On the other hand, Europe remains the world’s second-largest market for CIS insulin after North America. FMI’s latest CIS insulin market projections further reveal that countries like Germany, France, and the UK will emerge as the most lucrative markets for CIS insulin across Europe during the forecast period.

Customize this Report

Let us know your requirement to get
100% FREE customization

CIS Insulin Market Demand Analysis (2015 to 2021) Vs Market Outlook (2022 to 2032)

Increased spending on healthcare and advancements in healthcare infrastructure will continue to hold a positive influence on CIS insulin market growth

As per Future Market Insights, the global demand for the CIS Insulin market is anticipated to grow at a CAGR of 2.7% during the forecast period between 2022 and 2032, in comparison to a 2.2% CAGR registered from 2015 to 2021.

Growth in the CIS insulin market is driven by it the increasing prevalence of diabetes patients and changing lifestyles and eating habits resulting in health disorders such as obesity and other metabolic diseases, surging investments in R&D, innovations in insulin products, and a rise in CIS insulin applications for type I and type II diabetes.

Similarly, increasing government initiatives and investments to provide for high-quality diagnosis, particularly across developed nations like the United States, United Kingdom, and China will expand the CIS insulin market size during the forthcoming years.

According to the World Health Organization, about 422 million people worldwide have diabetes, the majority living in low-and middle-income countries, and 1.5 million deaths are directly attributed to diabetes each year. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few decades.

CIS Insulin Market Download Report Brochure

Which Factors Are Restraining the Growth of the CIS Insulin Market?

Despite optimistic growth projection, the global CIS insulin market is facing various obstacles that are restraining its growth to some extent. Some of these factors include the adverse effect of insulin therapy like hypoglycemia and pain at the site of injection may impact the use among some individuals.

Also, other disadvantages such as weight gain, electrolyte imbalance, and, in rare cases, peripheral hyperinsulinemia, decreased compliance, and high nocturnal glucose levels also lower the growth of the CIS insulin market. Increasing incidence of insulin resistance, particularly among obese individuals may restrain the growth of the market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-wise Analysis of the CIS Insulin Market

Which Factors Are Pushing the CIS Insulin Market in the U.S?

Initiatives to curb diabetes to drive the CIS Insulin Market in the U.S”

Over the years, CIS insulin sales have risen at a substantial pace across US and the trend is likely to continue even during the forecast period, owing to the rapid surge in the number of diabetic people, due to the rising healthcare spending, favorable government initiatives, and presence of large number of CIS Insulin market players in the region.

North America is anticipated to lead the global CIS insulin market during the forecast period, with the U.S expected to lead across the region. As per Future Market Insights, the market in the U.S is likely to garner US$ 257 Million while exhibiting a CAGR of 4.6% from 2022 to 2032.

North America is expected to hold a large share in the global CIS insulin market due to the presence of leading technological advancements in the healthcare sector and increasing expenditure on healthcare by governments. Similarly, with an increase in the number of hospitals and healthcare facilities with the advancements in technology, many new products are being introduced in the global CIS insulin market will boost sales to new heights.

For instance, Novo Nordisk launched its smart insulin pen which comes with inbuilt Bluetooth. The smart pen can record the dose of insulin and maintain timely logs. The best part about this pen is that it does not pain that much when compared to normal insulin pens.

How Will Growth Unfold in the Europe Clinical Decision Support Market?

“Rapid technological advances in healthcare to boost the growth of the CIS insulin market in Europe”

As per FMI, the CIS insulin market in Europe is poised to exhibit strong growth on the back of surging technologically advanced research & treatment platforms for the diagnosis of chronic diseases, expanding healthcare infrastructure, and advancement in IT healthcare organizations. Also, increasing awareness and greater spending on healthcare treatments and procedures. With such as acceleration in the healthcare industry, manufacturers of CIS insulin are focusing on leading economies to strengthen their market footprint globally.

The rapid technological development and extensive government initiatives for the production and the regulation of price increases will boost the growth of the CIS insulin market across Europe during the forthcoming period. Amongst all countries, the U.K is slated to emerge as the most lucrative in Europe, expected to flourish at a 3.4% CAGR until 2032, reaching US$ 33 Million.

Category-wise Analysis

Which Product Type Segment Dominates the Global CIS Insulin Market?

“Rapid Acting CIS Insulin to experience Maximum Uptake

Based on product type, rapid-acting CIS insulin is likely to account for maximum growth, growing at a 2.2% CAGR. As rapid-acting insulins work very quickly to minimize the rise in blood sugar after eating and their effect lasts for a couple of hours. This type of insulin is often used with longer-acting insulin for maintaining blood glucose for a longer period.

Rapid-acting insulin replaces the insulin that is normally produced by the body and by helping sugar move from the blood into other body tissues where it is used for energy inhibiting the liver from producing more sugar is another factor that makes them a preferred choice among physicians as well as patients. This will boost the demand for the segment in the forecasting period.

By Application Which Segment Holds the Maximum Potential for CIS Insulin Market Growth?

“Treatment for Type I and other Diabetes to Contribute a Significant Portion to Market Growth”

Based on application, FMI’s latest report on the CIS insulin market forecast Type I and Other Diabetes segment to grow at a CAGR of 2.1% during the assessment period. The increasing diagnosis rate of type I and other diabetes boost the growth of the segment.

According to the International Diabetic Federation around 10% of all people with diabetes have type 1 diabetes. All people with type 1 diabetes need to take insulin to control their blood glucose levels. Increasing the production of insulin in developed countries and various new products will boost the growth of the segment.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Who are the Leading Players in CIS Insulin Market?

Some of the leading cis insulin include Novo Nordisk, Sanofi, Eli Lilly, Bristol-Myers Squibb and Novartis among others. These key CIS Insulin providers are adopting various strategies such as new product launches and approvals, partnerships, collaborations, acquisitions, mergers, etc. to increase their sales and gain a competitive edge in the global CIS Insulin market.

  • In June 2022- Lilly presented the new mechanism of action data and new analyses of of Mounjaro™ (tirzepatide) injection for the treatment of adults with type 2 diabetes at the American Diabetes Association's® 82nd Scientific Sessions.
  • In November 2021 Novo Nordisk announced the acquisition of Dicerna Pharmaceuticals (Dicerna) to discover and develop RNAi therapies using Dicerna’s proprietary GalXC™ RNAi platform technology.
  • In February 2022 — Novartis India Limited (NIL) announced an exclusive sales and distribution agreement with Dr. Reddy’s Laboratories (Dr. Reddy’s) for a few of its Established Medicines which includes the Voveran range, the Calcium range and Methergine.
  • In January 2022- Bristol Myers Squibb and Century Therapeutics announced collaboration and license agreement develop and commercialize up to four induced pluripotent stem cell (“iPSC”) derived, engineered natural killer cell (“iNK”) and / or T cell (“iT”) programs for hematologic malignancies and solid tumors.

Report Scope

Report Attribute

Details

Growth Rate

2.7% CAGR from 2022 to 2032

Market Value for 2022

US$ 465 Million

Market Value for 2032

US$ 600 Million

Base Year for Estimation

2021

Historical Data

2015-2021

Forecast Period

2022-2032

Quantitative Units

US$ Million for Value

Report Coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis

Segments Covered

  • Product Type
  • Application
  • Source
  • Region

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • France
  • U.K
  • Italy
  • BENELUX
  • Nordics
  • China
  • Japan
  • South Korea
  • GCC
  • South Africa
  • Turkey

Key Companies Profiled

  • Sanofi
  • Eli Lilly
  • Bristol-Myers Squibb
  • Novartis
  • Takeda Pharmaceuticals
  • Boehringer Ingelheim
  • Biocon
  • Dongbao Enterprise Group Co. Ltd.
  • Merck KGaA
  • Oramed Pharmaceuticals Inc.
  • Halozyme Therapeutics
  • Wanbang Biopharma
  • Xinbai Pharmaceutical
  • Indrar
  • Farmak

Report Customization & Pricing

Available upon Request

Key Segments Profiled in the CIS Insulin Industry Survey

CIS Insulin Market by Product Type:

  • Rapid Acting CIS Insulin
  • Long Acting CIS Insulin
  • Premixed CIS Insulin
  • Premixed Analog CIS Insulin
  • Short-Acting CIS Insulin
  • Intermediate-Acting CIS Insulin

CIS Insulin Market by Application:

  • CIS Insulin for treating Type I and Other Diabetes
  • CIS Insulin for treating Type II Diabetes

CIS Insulin Market by Source:

  • Human Recombinant CIS Insulin
  • Analogs-based CIS Insulin

CIS Insulin Market by Region:

  • North America CIS Insulin Market
  • Latin America CIS Insulin Market
  • Europe CIS Insulin Market
  • Asia & Pacific CIS Insulin Market
  • Middle East & Africa (MEA) CIS Insulin Market

Frequently Asked Questions

The global CIS insulin market is likely to reach US$ 465 Million in 2022

As per FMI, the CIS insulin industry is expected to grow at a CAGR of 2.7% throughout the forecast period (2022-2032).

The global sales of CIS insulin systems are anticipated to total a valuation of US$ 600 Million by 2032.

Some of the leading CIS insulin manufacturers include Novo Nordisk, Sanofi, Eli Lilly, Bristol-Myers Squibb, and Novartis

U.S will continue to remain the most lucrative market for CIS insulin accounting for the market value of US$ 257Million 2032

Increasing technological advancement in the healthcare sector and an increase in the incidence of diabetes patients are some of the major factors shaping the growth of the CIS insulin market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on CIS Insulin Market

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. CIS Insulin Market, by Key Countries

    4.2. CIS Insulin Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. CIS Insulin Market Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. CIS Insulin Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global CIS Insulin Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global CIS Insulin Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global CIS Insulin Market Analysis 2015-2021 and Forecast 2022-2032, By Product Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2022-2032

        8.3.1. Rapid acting

        8.3.2. Long acting

        8.3.3. Premixed

        8.3.4. Premixed analog

        8.3.5. Short acting

        8.3.6. Intermediate acting

    8.4. Market Attractiveness Analysis By Product Type

9. Global CIS Insulin Market Analysis 2015-2021 and Forecast 2022-2032, By Application

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Application, 2015-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032

        9.3.1. Type I and Other Diabetes

        9.3.2. Type II Diabetes

    9.4. Market Attractiveness Analysis By Application

10. Global CIS Insulin Market Analysis 2015-2021 and Forecast 2022-2032, By Source

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Source, 2015-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Source, 2022-2032

        10.3.1. Human Recombinant Insulin

        10.3.2. Analogs

    10.4. Market Attractiveness Analysis By Source

11. Global CIS Insulin Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America CIS Insulin Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By Product Type

        12.4.3. By Source

        12.4.4. By Application

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Product Type

        12.5.3. By Source

        12.5.4. By Application

13. Latin America CIS Insulin Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By Product Type

        13.4.3. By Source

        13.4.4. By Application

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product Type

        13.5.3. By Source

        13.5.4. By Application

14. Europe CIS Insulin Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. U.K.

            14.4.1.4. Italy

            14.4.1.5. Benelux

            14.4.1.6. Nordic Countries

            14.4.1.7. Rest of Europe

        14.4.2. By Product Type

        14.4.3. By Source

        14.4.4. By Application

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product Type

        14.5.3. By Source

        14.5.4. By Application

15. Asia Pacific CIS Insulin Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Rest of Asia Pacific

        15.4.2. By Product Type

        15.4.3. By Source

        15.4.4. By Application

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product Type

        15.5.3. By Source

        15.5.4. By Application

16. Middle East and Africa CIS Insulin Market Analysis 2015-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. GCC Countries

            16.4.1.2. South Africa

            16.4.1.3. Turkey

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By Product Type

        16.4.3. By Source

        16.4.4. By Application

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product Type

        16.5.3. By Source

        16.5.4. By Application

17. Key Countries CIS Insulin Market Analysis 2015-2021 and Forecast 2022-2032

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. US CIS Insulin Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.2.2.1. By Product Type

            17.2.2.2. By Source

            17.2.2.3. By Application

    17.3. Canada CIS Insulin Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.3.2.1. By Product Type

            17.3.2.2. By Source

            17.3.2.3. By Application

    17.4. Mexico CIS Insulin Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.4.2.1. By Product Type

            17.4.2.2. By Source

            17.4.2.3. By Application

    17.5. Brazil CIS Insulin Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.5.2.1. By Product Type

            17.5.2.2. By Source

            17.5.2.3. By Application

    17.6. Germany CIS Insulin Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.6.2.1. By Product Type

            17.6.2.2. By Source

            17.6.2.3. By Application

    17.7. France CIS Insulin Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.7.2.1. By Product Type

            17.7.2.2. By Source

            17.7.2.3. By Application

    17.8. Italy CIS Insulin Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.8.2.1. By Product Type

            17.8.2.2. By Source

            17.8.2.3. By Application

    17.9. BENELUX CIS Insulin Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.9.2.1. By Product Type

            17.9.2.2. By Source

            17.9.2.3. By Application

    17.10. UK CIS Insulin Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.10.2.1. By Product Type

            17.10.2.2. By Source

            17.10.2.3. By Application

    17.11. Nordic Countries CIS Insulin Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.11.2.1. By Product Type

            17.11.2.2. By Source

            17.11.2.3. By Application

    17.12. China CIS Insulin Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.12.2.1. By Product Type

            17.12.2.2. By Source

            17.12.2.3. By Application

    17.13. Japan CIS Insulin Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.13.2.1. By Product Type

            17.13.2.2. By Source

            17.13.2.3. By Application

    17.14. South Korea CIS Insulin Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.14.2.1. By Product Type

            17.14.2.2. By Source

            17.14.2.3. By Application

    17.15. GCC Countries CIS Insulin Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.15.2.1. By Product Type

            17.15.2.2. By Source

            17.15.2.3. By Application

    17.16. South Africa CIS Insulin Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.16.2.1. By Product Type

            17.16.2.2. By Source

            17.16.2.3. By Application

    17.17. Turkey CIS Insulin Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            17.17.2.1. By Product Type

            17.17.2.2. By Source

            17.17.2.3. By Application

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. Novo Nordisk

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. Sanofi

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. Eli Lilly

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. Bristol-Myers Squibb

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. Novartis

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. Takeda Pharmaceuticals

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Strategy Overview

        19.3.7. Boehringer Ingelheim

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. Biocon

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. Dongbao Enterprise Group Co., Ltd.

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overvie

        19.3.10. Merck KGaA

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Sales Footprint

            19.3.10.4. Strategy Overview

        19.3.11. Oramed Pharmaceuticals Inc.

            19.3.11.1. Overview

            19.3.11.2. Product Portfolio

            19.3.11.3. Sales Footprint

            19.3.11.4. Strategy Overview

        19.3.12. Halozyme Therapeutics

            19.3.12.1. Overview

            19.3.12.2. Product Portfolio

            19.3.12.3. Sales Footprint

            19.3.12.4. Strategy Overview

        19.3.13. Wanbang Biopharma

            19.3.13.1. Overview

            19.3.13.2. Product Portfolio

            19.3.13.3. Sales Footprint

            19.3.13.4. Strategy Overview

        19.3.14. Xinbai Pharmaceutical

            19.3.14.1. Overview

            19.3.14.2. Product Portfolio

            19.3.14.3. Sales Footprint

            19.3.14.4. Strategy Overview

        19.3.15. Gan & Lee Pharmaceutical

            19.3.15.1. Overview

            19.3.15.2. Product Portfolio

            19.3.15.3. Sales Footprint

            19.3.15.4. Strategy Overview

        19.3.16. Indrar

            19.3.16.1. Overview

            19.3.16.2. Product Portfolio

            19.3.16.3. Sales Footprint

            19.3.16.4. Strategy Overview

        19.3.17. Farmak

            19.3.17.1. Overview

            19.3.17.2. Product Portfolio

            19.3.17.3. Sales Footprint

            19.3.17.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global CIS Insulin Market Value (US$ Mn), By Product Type, 2015 – 2021

Table 2: Global CIS Insulin Market Value (US$ Mn), By Product Type, 2022 – 2032

Table 3: Global CIS Insulin Market Value (US$ Mn), By Source, 2015 – 2021

Table 4: Global CIS Insulin Market Value (US$ Mn), By Source, 2022 – 2032

Table 5: Global CIS Insulin Market Value (US$ Mn), By Application, 2015 – 2021

Table 6: Global CIS Insulin Market Value (US$ Mn), By Application, 2022 – 2032

Table 7: Global CIS Insulin Market, By Region, 2015 – 2021

Table 8: Global CIS Insulin Market, By Region, 2022 – 2032

Table 9: North America CIS Insulin Market Value (US$ Mn), By Product Type, 2015 – 2021

Table 10: North America CIS Insulin Market Value (US$ Mn), By Product Type, 2022 – 2032

Table 11: North America CIS Insulin Market Value (US$ Mn), By Source, 2015 – 2021

Table 12: North America CIS Insulin Market Value (US$ Mn), By Source, 2022 – 2032

Table 13: North America CIS Insulin Market Value (US$ Mn), By Application, 2015 – 2021

Table 14: North America CIS Insulin Market Value (US$ Mn), By Application, 2022 – 2032

Table 15: North America CIS Insulin Market, By Country, 2015 – 2021

Table 16: North America CIS Insulin Market, By Country, 2022 – 2032

Table 17: Latin America CIS Insulin Market Value (US$ Mn), By Product Type, 2015 – 2021

Table 18: Latin America CIS Insulin Market Value (US$ Mn), By Product Type, 2022 – 2032

Table 19: Latin America CIS Insulin Market Value (US$ Mn), By Source, 2015 – 2021

Table 20: Latin America CIS Insulin Market Value (US$ Mn), By Source, 2022 – 2032

Table 21: Latin America CIS Insulin Market Value (US$ Mn), By Application, 2015 – 2021

Table 22: Latin America CIS Insulin Market Value (US$ Mn), By Application, 2022 – 2032

Table 23: Latin America CIS Insulin Market, By Country, 2015 – 2021

Table 24: Latin America CIS Insulin Market, By Country, 2022 – 2032

Table 25: Europe CIS Insulin Market Value (US$ Mn), By Product Type, 2015 – 2021

Table 26: Europe CIS Insulin Market Value (US$ Mn), By Product Type, 2022 – 2032

Table 27: Europe CIS Insulin Market Value (US$ Mn), By Source, 2015 – 2021

Table 28: Europe CIS Insulin Market Value (US$ Mn), By Source, 2022 – 2032

Table 29: Europe CIS Insulin Market Value (US$ Mn), By Application, 2015 – 2021

Table 30: Europe CIS Insulin Market Value (US$ Mn), By Application, 2022 – 2032

Table 31: Europe CIS Insulin Market, By Country, 2015 – 2021

Table 32: Europe CIS Insulin Market, By Country, 2022 – 2032

Table 33: Asia Pacific CIS Insulin Market Value (US$ Mn), By Product Type, 2015 – 2021

Table 34: Asia Pacific CIS Insulin Market Value (US$ Mn), By Product Type, 2022 – 2032

Table 35: Asia Pacific CIS Insulin Market Value (US$ Mn), By Source, 2015 – 2021

Table 36: Asia Pacific CIS Insulin Market Value (US$ Mn), By Source, 2022 – 2032

Table 37: Asia Pacific CIS Insulin Market Value (US$ Mn), By Application, 2015 – 2021

Table 38: Asia Pacific CIS Insulin Market Value (US$ Mn), By Application, 2022 – 2032

Table 39: Asia Pacific CIS Insulin Market, By Country, 2015 – 2021

Table 40: Asia Pacific CIS Insulin Market, By Country, 2022 – 2032

Table 41: MEA CIS Insulin Market Value (US$ Mn), By Product Type, 2015 – 2021

Table 42: MEA CIS Insulin Market Value (US$ Mn), By Product Type, 2022 – 2032

Table 43: MEA CIS Insulin Market Value (US$ Mn), By Source, 2015 – 2021

Table 44: MEA CIS Insulin Market Value (US$ Mn), By Source, 2022 – 2032

Table 45: MEA CIS Insulin Market Value (US$ Mn), By Application, 2015 – 2021

Table 46: MEA CIS Insulin Market Value (US$ Mn), By Application, 2022 – 2032

Table 47: MEA CIS Insulin Market, By Country, 2015 – 2021

Table 48: MEA CIS Insulin Market, By Country, 2022 – 2032

Table 49: Global CIS Insulin Market Incremental $ Opportunity, By Product Type, 2015 - 2021

Table 50: Global CIS Insulin Market Incremental $ Opportunity, By Source, 2022 – 2032

Table 51: Global CIS Insulin Market Incremental $ Opportunity, By Application, 2015 - 2021

Table 52: Global CIS Insulin Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 53: North America CIS Insulin Market Incremental $ Opportunity, By Product Type, 2015 - 2021

Table 54: North America CIS Insulin Market Incremental $ Opportunity, By Source, 2022 – 2032

Table 55: North America CIS Insulin Market Incremental $ Opportunity, By Application, 2015 – 2021

Table 56: North America CIS Insulin Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 57: Latin America CIS Insulin Market Incremental $ Opportunity, By Product Type, 2015 - 2021

Table 58: Latin America CIS Insulin Market Incremental $ Opportunity, By Source, 2022 – 2032

Table 59: Latin America CIS Insulin Market Incremental $ Opportunity, By Application, 2015 - 2021

Table 60: Latin America CIS Insulin Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 61: Europe CIS Insulin Market Incremental $ Opportunity, By Product Type, 2015 - 2021

Table 62: Europe CIS Insulin Market Incremental $ Opportunity, By Source, 2022 – 2032

Table 63: Europe CIS Insulin Market Incremental $ Opportunity, By Application, 2015 - 2021

Table 64: Europe CIS Insulin Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 65: Asia Pacific CIS Insulin Market Incremental $ Opportunity, By Product Type, 2015 - 2021

Table 66: Asia Pacific CIS Insulin Market Incremental $ Opportunity, By Source, 2022 – 2032

Table 67: Asia Pacific CIS Insulin Market Incremental $ Opportunity, By Application, 2015 - 2021

Table 68: Asia Pacific CIS Insulin Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 69: MEA CIS Insulin Market Incremental $ Opportunity, By Product Type, 2015 - 2021

Table 70: MEA CIS Insulin Market Incremental $ Opportunity, By Source, 2022 – 2032

Table 71: MEA CIS Insulin Market Incremental $ Opportunity, By Application, 2015 - 2021

Table 72: MEA CIS Insulin Market Incremental $ Opportunity, By Country, 2022 - 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global CIS Insulin Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global CIS Insulin Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global CIS Insulin Market Share, By Product Type, 2022 & 2032

Figure 4: Global CIS Insulin Market Y-o-Y Growth Projections, By Product Type – 2022-2032

Figure 5: Global CIS Insulin Market Attractiveness Index, By Product Type – 2022-2032

Figure 6: Global CIS Insulin Market Share, By Source, 2022 & 2032

Figure 7: Global CIS Insulin Market Y-o-Y Growth Projections, By Source – 2022-2032

Figure 8: Global CIS Insulin Market Attractiveness Index, By Source – 2022-2032

Figure 9: Global CIS Insulin Market Share, By Application, 2022 & 2032

Figure 10: Global CIS Insulin Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 11: Global CIS Insulin Market Attractiveness Index, By Application – 2022-2032

Figure 12: Global CIS Insulin Market Share, By Region, 2022 & 2032

Figure 13: Global CIS Insulin Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 14: Global CIS Insulin Market Attractiveness Index, By Region – 2022-2032

Figure 15: North America CIS Insulin Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 16: North America CIS Insulin Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 17: North America CIS Insulin Market Share, By Product Type, 2022 & 2032

Figure 18: North America CIS Insulin Market Y-o-Y Growth Projections, By Product Type – 2022-2032

Figure 19: North America CIS Insulin Market Attractiveness Index, By Product Type – 2022-2032

Figure 20: North America CIS Insulin Market Share, By Source, 2022 & 2032

Figure 21: North America CIS Insulin Market Y-o-Y Growth Projections, By Source – 2022-2032

Figure 22: North America CIS Insulin Market Attractiveness Index, By Source – 2022-2032

Figure 23: North America CIS Insulin Market Share, By Application, 2022 & 2032

Figure 24: North America CIS Insulin Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 25: North America CIS Insulin Market Attractiveness Index, By Application – 2022-2032

Figure 26: North America CIS Insulin Market Share, By Country, 2022 & 2032

Figure 27: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 28: North America Market Attractiveness Index, By Country – 2022-2032

Figure 29: Latin America CIS Insulin Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 30: Latin America CIS Insulin Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 31: Latin America CIS Insulin Market Share, By Product Type, 2022 & 2032

Figure 32: Latin America CIS Insulin Market Y-o-Y Growth Projections, By Product Type – 2022-2032

Figure 33: Latin America CIS Insulin Market Attractiveness Index, By Product Type – 2022-2032

Figure 34: Latin America CIS Insulin Market Share, By Source, 2022 & 2032

Figure 35: Latin America CIS Insulin Market Y-o-Y Growth Projections, By Source – 2022-2032

Figure 36: Latin America CIS Insulin Market Attractiveness Index, By Source – 2022-2032

Figure 37: Latin America CIS Insulin Market Share, By Application, 2022 & 2032

Figure 38: Latin America CIS Insulin Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 39: Latin America CIS Insulin Market Attractiveness Index, By Application – 2022-2032

Figure 40: Latin America CIS Insulin Market Share, By Country, 2022 & 2032

Figure 41: Latin America CIS Insulin Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 42: Latin America CIS Insulin Market Attractiveness Index, By Country – 2022-2032

Figure 43: Europe CIS Insulin Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 44: Europe CIS Insulin Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 45: Europe CIS Insulin Market Share, By Product Type, 2022 & 2032

Figure 46: Europe CIS Insulin Market Y-o-Y Growth Projections, By Product Type – 2022-2032

Figure 47: Europe CIS Insulin Market Attractiveness Index, By Product Type – 2022-2032

Figure 48: Europe CIS Insulin Market Share, By Source, 2022 & 2032

Figure 49: Europe CIS Insulin Market Y-o-Y Growth Projections, By Source – 2022-2032

Figure 50: Europe CIS Insulin Market Attractiveness Index, By Source – 2022-2032

Figure 51: Europe CIS Insulin Market Share, By Application, 2022 & 2032

Figure 52: Europe CIS Insulin Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 53: Europe CIS Insulin Market Attractiveness Index, By Application – 2022-2032

Figure 54: Europe CIS Insulin Market Share, By Country, 2022 & 2032

Figure 55: Europe CIS Insulin Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 56: Europe CIS Insulin Market Attractiveness Index, By Country – 2022-2032

Figure 57: MEA CIS Insulin Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 58: MEA CIS Insulin Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 59: MEA CIS Insulin Market Share, By Product Type, 2022 & 2032

Figure 60: MEA CIS Insulin Market Y-o-Y Growth Projections, By Product Type – 2022-2032

Figure 61: MEA CIS Insulin Market Attractiveness Index, By Product Type – 2022-2032

Figure 62: MEA CIS Insulin Market Share, By Source, 2022 & 2032

Figure 63: MEA CIS Insulin Market Y-o-Y Growth Projections, By Source – 2022-2032

Figure 64: MEA CIS Insulin Market Attractiveness Index, By Source – 2022-2032

Figure 65: MEA CIS Insulin Market Share, By Application, 2022 & 2032

Figure 66: MEA CIS Insulin Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 67: MEA CIS Insulin Market Attractiveness Index, By Application – 2022-2032

Figure 68: MEA CIS Insulin Market Share, By Country, 2022 & 2032

Figure 69: MEA CIS Insulin Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 70: MEA CIS Insulin Market Attractiveness Index, By Country – 2022-2032

Figure 71: Asia Pacific CIS Insulin Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 72: Asia Pacific CIS Insulin Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 73: Asia Pacific CIS Insulin Market Share, By Product Type, 2022 & 2032

Figure 74: Asia Pacific CIS Insulin Market Y-o-Y Growth Projections, By Product Type – 2022-2032

Figure 75: Asia Pacific CIS Insulin Market Attractiveness Index, By Product Type – 2022-2032

Figure 76: Asia Pacific CIS Insulin Market Share, By Source, 2022 & 2032

Figure 77: Asia Pacific CIS Insulin Market Y-o-Y Growth Projections, By Source – 2022-2032

Figure 78: Asia Pacific CIS Insulin Market Attractiveness Index, By Source – 2022-2032

Figure 79: Asia Pacific CIS Insulin Market Share, By Application, 2022 & 2032

Figure 80: Asia Pacific CIS Insulin Market Y-o-Y Growth Projections, By Application – 2022-2032

Figure 81: Asia Pacific CIS Insulin Market Attractiveness Index, By Application – 2022-2032

Figure 82: Asia Pacific CIS Insulin Market Share, By Country, 2022 & 2032

Figure 83: Asia Pacific CIS Insulin Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 84: Asia Pacific CIS Insulin Market Attractiveness Index, By Country – 2022-2032

Figure 85: US CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 86: US CIS Insulin Market Share, By Product Type, 2021

Figure 87: US CIS Insulin Market Share, By Source, 2021

Figure 88: US CIS Insulin Market Share, By Application, 2021

Figure 89: Canada CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 90: Canada CIS Insulin Market Share, By Product Type, 2021

Figure 91: Canada CIS Insulin Market Share, By Source, 2021

Figure 92: Canada CIS Insulin Market Share, By Application, 2021

Figure 93: Brazil CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 94: Brazil CIS Insulin Market Share, By Product Type, 2021

Figure 95: Brazil CIS Insulin Market Share, By Source, 2021

Figure 96: Brazil CIS Insulin Market Share, By Application, 2021

Figure 97: Mexico CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 98: Mexico CIS Insulin Market Share, By Product Type, 2021

Figure 99: Mexico CIS Insulin Market Share, By Source, 2021

Figure 100: Mexico CIS Insulin Market Share, By Application, 2021

Figure 101: Germany CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 102: Germany CIS Insulin Market Share, By Product Type, 2021

Figure 103: Germany CIS Insulin Market Share, By Source, 2021

Figure 104: Germany CIS Insulin Market Share, By Application, 2021

Figure 105: U.K. CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 106: U.K. CIS Insulin Market Share, By Product Type, 2021

Figure 107: U.K. CIS Insulin Market Share, By Source, 2021

Figure 108: U.K. CIS Insulin Market Share, By Application, 2021

Figure 109: France CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 110: France CIS Insulin Market Share, By Product Type, 2021

Figure 111: France CIS Insulin Market Share, By Source, 2021

Figure 112: France CIS Insulin Market Share, By Application, 2021

Figure 113: Italy CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 114: Italy CIS Insulin Market Share, By Product Type, 2021

Figure 115: Italy CIS Insulin Market Share, By Source, 2021

Figure 116: Italy CIS Insulin Market Share, By Application, 2021

Figure 117: BENELUX CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 118: BENELUX CIS Insulin Market Share, By Product Type, 2021

Figure 119: BENELUX CIS Insulin Market Share, By Source, 2021

Figure 120: BENELUX CIS Insulin Market Share, By Application, 2021

Figure 121: Nordic Countries CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 122: Nordic Countries CIS Insulin Market Share, By Product Type, 2021

Figure 123: Nordic Countries CIS Insulin Market Share, By Source, 2021

Figure 124: Nordic Countries CIS Insulin Market Share, By Application, 2021

Figure 125: China CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 126: China CIS Insulin Market Share, By Product Type, 2021

Figure 127: China CIS Insulin Market Share, By Source, 2021

Figure 128: China CIS Insulin Market Share, By Application, 2021

Figure 129: Japan CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 130: Japan CIS Insulin Market Share, By Product Type, 2021

Figure 131: Japan CIS Insulin Market Share, By Source, 2021

Figure 132: Japan CIS Insulin Market Share, By Application, 2021

Figure 133: South Korea CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 134: South Korea CIS Insulin Market Share, By Product Type, 2021

Figure 135: South Korea CIS Insulin Market Share, By Source, 2021

Figure 136: South Korea CIS Insulin Market Share, By Application, 2021

Figure 137: GCC Countries CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 138: GCC Countries CIS Insulin Market Share, By Product Type, 2021

Figure 139: GCC Countries CIS Insulin Market Share, By Source, 2021

Figure 140: GCC Countries CIS Insulin Market Share, By Application, 2021

Figure 141: South Africa CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 142: South Africa CIS Insulin Market Share, By Product Type, 2021

Figure 143: South Africa CIS Insulin Market Share, By Source, 2021

Figure 144: South Africa CIS Insulin Market Share, By Application, 2021

Figure 145: Turkey CIS Insulin Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 146: Turkey CIS Insulin Market Share, By Product Type, 2021

Figure 147: Turkey CIS Insulin Market Share, By Source, 2021

Figure 148: Turkey CIS Insulin Market Share, By Application, 2021

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Insulin Delivery Pens Market

Published : November 2017

Healthcare

Insulin Patch Pump Market

Published : April 2017

Healthcare

Insulin Management System Market

Published : December 2016

Healthcare

Insulin Biosimilars Market

Published : September 2016

Google translate